Login / Signup

Quality use of medicines in patients with chronic kidney disease.

Ronald Lynel CastelinoTimothy SaunderAlex KitsosGregory M PetersonMatthew JoseBarbara WimmerMasuma KhanamWoldesellassie BezabheJim StankovichJan Radford
Published in: BMC nephrology (2020)
This study highlights that PIP commonly occurs in primary care patients with CKD and the need for further research to understand why and how this can be minimised. The findings also show that the eGFR provides clinicians a potential alternative to the CG formula when estimating kidney function to guide drug appropriateness and dosing.
Keyphrases
  • primary care
  • small cell lung cancer
  • chronic kidney disease
  • epidermal growth factor receptor
  • palliative care
  • emergency department
  • adverse drug
  • climate change
  • electronic health record